Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

[Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer].

Kawada J, Iwase K, Deguchi K, Higashi S, Deguchi T, Matsuda C, Tamagawa H, Omori K, Nishikawa K, Nomura M, Takagi M, Fukui A, Tanaka Y.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2095-7. Japanese.

PMID:
23267988
[PubMed - indexed for MEDLINE]
2.

[Efficacy and safety of biweekly nedaplatin in combination with docetaxel as second-line chemotherapy in patients with unresectable or recurrent esophageal cancer].

Irino T, Egawa T, Kenmochi T, Ito Y, Mihara K, Okamura A, Eto E, Inaba Y, Murakawa M, Nagashima A.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2401-4. Japanese.

PMID:
22202395
[PubMed - indexed for MEDLINE]
3.

Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.

Jin J, Xu X, Wang F, Yan G, Liu J, Lu W, Li X, Tucker SJ, Zhong B, Cao Z, Wang D.

J Thorac Oncol. 2009 Aug;4(8):1017-21. doi: 10.1097/JTO.0b013e3181add9c7.

PMID:
19542899
[PubMed - indexed for MEDLINE]
4.

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.

Yamazaki K, Hironaka S, Boku N, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Hasuike N, Inui T, Yamaguchi Y, Ono H.

Int J Clin Oncol. 2008 Apr;13(2):150-5. doi: 10.1007/s10147-007-0738-y. Epub 2008 May 8.

PMID:
18463960
[PubMed - indexed for MEDLINE]
5.

A pilot trial of docetaxel and nedaplatin in cisplatin-pretreated relapsed or refractory esophageal squamous cell cancer.

Nakajima Y, Suzuki T, Haruki S, Ogiya K, Kawada K, Nishikage T, Nagai K, Kawano T.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1631-5.

PMID:
19102357
[PubMed - indexed for MEDLINE]
6.

A combined therapy with docetaxel and nedaplatin for relapsed and metastatic esophageal carcinoma.

Matsumoto H, Hirabayashi Y, Kubota H, Murakami H, Higashida M, Haruma K, Hiratsuka J, Nakamura M, Hirai T.

Anticancer Res. 2012 May;32(5):1827-31.

PMID:
22593469
[PubMed - indexed for MEDLINE]
7.

Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer.

Kanai M, Matsumoto S, Nishimura T, Shimada Y, Watanabe G, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Teramukai S, Mitsumori M, Chiba T, Sakai Y, Fukushima M.

Int J Clin Oncol. 2007 Jun;12(3):224-7. Epub 2007 Jun 27.

PMID:
17566847
[PubMed - indexed for MEDLINE]
8.

[A feasible study of docetaxel/nedaplatin combined chemotherapy for relapsed or refractory esophageal cancer patients as a 2nd-line chemotherapy].

Matsumoto H, Hirai T, Hirabayashi Y, Murakami H, Higashida M, Kawabe Y, Urakami A, Yamashita K, Tsunoda T.

Gan To Kagaku Ryoho. 2007 May;34(5):725-8. Japanese.

PMID:
17496445
[PubMed - indexed for MEDLINE]
9.

Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.

Osaka Y, Takagi Y, Hoshino S, Tachibana S, Tsuchida A, Aoki T.

Dis Esophagus. 2006;19(6):473-6.

PMID:
17069591
[PubMed - indexed for MEDLINE]
10.

Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.

Fujita Y, Hiramatsu M, Kawai M, Sumiyoshi K, Nishimura H, Tanigawa N.

Dis Esophagus. 2008;21(6):496-501. doi: 10.1111/j.1442-2050.2007.00806.x.

PMID:
18840134
[PubMed - indexed for MEDLINE]
11.

A phase 1/11 study of second-line chemotherapy with fractionated docetaxel and nedaplatin for 5-FU/cisplatin-resistant esophageal squamous cell carcinoma.

Akutsu Y, Shuto K, Kono T, Uesato M, Hoshino I, Shiratori T, Miyazawa Y, Isozaki Y, Akanuma N, Matsubara H.

Hepatogastroenterology. 2012 Oct;59(119):2095-8.

PMID:
22328303
[PubMed - indexed for MEDLINE]
12.

A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.

Guo JF, Zhang B, Wu F, Wang B, Xing H, Zhu GY, Nie XY, Peng J.

Chin J Cancer. 2010 Mar;29(3):321-4.

PMID:
20193118
[PubMed - indexed for MEDLINE]
Free Article
13.

Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.

Tanaka T, Fujita H, Sueyoshi S, Tanaka Y, Sasahara H, Mori N, Nagano T, Yamana H, Shirouzu K.

Chemotherapy. 2007;53(6):449-53. Epub 2007 Oct 22.

PMID:
17952006
[PubMed - indexed for MEDLINE]
14.

Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma.

Goel G, Jauhri M, Negi A, Aggarwal S.

Hematol Oncol Stem Cell Ther. 2010;3(2):55-9.

PMID:
20543537
[PubMed - indexed for MEDLINE]
15.

Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.

Miyazaki T, Sohda M, Tanaka N, Suzuki S, Ieta K, Sakai M, Sano A, Yokobori T, Inose T, Nakajima M, Fukuchi M, Ojima H, Kato H, Kuwano H.

Cancer Chemother Pharmacol. 2013 Apr;71(4):853-7. doi: 10.1007/s00280-013-2076-2. Epub 2013 Jan 10.

PMID:
23306309
[PubMed - indexed for MEDLINE]
16.

A retrospective comparison of docetaxel and paclitaxel for patients with advanced or recurrent esophageal cancer who previously received platinum-based chemotherapy.

Mizota A, Shitara K, Kondo C, Nomura M, Yokota T, Takahari D, Ura T, Muro K.

Oncology. 2011;81(3-4):237-42. doi: 10.1159/000334057. Epub 2011 Nov 17.

PMID:
22094594
[PubMed - indexed for MEDLINE]
17.

Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.

Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC.

Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):27-31.

PMID:
14569845
[PubMed - indexed for MEDLINE]
18.

A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer.

Teramoto K, Asada Y, Ozaki Y, Suzumura Y, Nakano Y, Sawai S, Tezuka N, Inoue S, Fujino S.

Cancer Chemother Pharmacol. 2012 Oct;70(4):531-7. Epub 2012 Aug 5.

PMID:
22864949
[PubMed - indexed for MEDLINE]
19.

[A case of advanced esophageal cancer with no recurrence treated biweekly with postoperative docetaxel/nedaplatin combined chemotherapy after non-curative surgery].

Sugimoto K, Sasaki K, Karaki H, Okaya T, Suzuki H, Hayashi S, Yamamoto K, Yamamori H, Sugano I.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1101-3. Japanese.

PMID:
20567116
[PubMed - indexed for MEDLINE]
20.

[Docetaxel plus S-1 as a second-line chemotherapy for metastasis or recurrence of esophageal cancer].

Nakamura T, Ota M, Narumiya K, Sato T, Shirai Y, Yamamoto M, Kuramochi H, Hayashi K.

Gan To Kagaku Ryoho. 2012 Feb;39(2):227-30. Japanese.

PMID:
22333632
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk